Imaging in the Diagnosis and Management of Prostate Cancer

Reviews in Urology

Samir S Taneja¹ 

[1] Department of Urology, New York University School of Medicine, New York, NY

关键词: Prostate cancer;    MRI;    MRSI;    ProstaScint;    Combidex;   

DOI  :  

学科分类：基础医学

来源: MedReviews, LLC

【 摘 要 】

The current diagnosis and management of prostate cancer is largely based on the use of serum prostate-specific antigen (PSA) and pathologic risk factors such as Gleason score and clinical stage. The use of serum PSA in clinical practice has resulted in significant stage migration and, as such, imaging modalities historically utilized to stage prostate cancer are no longer able to reliably identify the small amounts of prostate cancer most often found at presentation. Molecular imaging techniques have focused on improving sensitivity and specificity for cancer detection through knowledge of specific attributes of disease biology. The evolution of imaging techniques has created a new role for imaging in the management of prostate cancer.

【 授权许可】

Unknown